Work

Clinical Implications of Compounds Designed to Inhibit ECM‐Modifying Metalloproteinases

Year: 2017

Type: review

Source: PROTEOMICS

DOI: 10.1002/pmic.201600389

Authors: Sabrina Amar, Dmitriy Minond, Gregg B. Fields

Institutions: Florida Atlantic University, Nova Southeastern University, Scripps Research Institute

Language: English

Topic: Protease and Inhibitor Mechanisms

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Lustgarten Foundation, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute on Drug Abuse, National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: G2522261593, G3198542394, G460905305, G5752054174, G5874609650, HTS for selective inhibitors of Meprin alpha and beta, G620117345

OpenAlex ID: W2755368862

FWCI: 0.307

Cites: 135

Cited by: 25

Related to: 10